Metabolic Research

Tesamorelin

Also known as: TH9507, Egrifta

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It is primarily studied for its ability to stimulate the pituitary gland to release endogenous growth hormone.

Molecular Properties

Molecular Formula

C221H366N72O67S

Molecular Weight

5135.9 g/mol

CAS Number

218949-48-5

Research History

Developed for the treatment of HIV-associated lipodystrophy, Tesamorelin has been extensively studied in clinical settings for its metabolic effects.

Studied Mechanisms

It acts as a potent agonist of the GHRH receptor, triggering the pulsatile release of GH and subsequently increasing insulin-like growth factor 1 (IGF-1) levels.

Storage Reference

Store lyophilized at -20°C. Once reconstituted, store at 2-8°C.

Handling Reference

Follow aseptic procedures; avoid vigorous shaking during reconstitution.